Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Bullboard (GREY:IMVIF)

View:
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
Comment by qwerty22on Apr 07, 2021 10:08am

RE:RE:Hmm. So, collaboration continues?

I hate when biotech put out statements that seem to say something and nothing at the same time. So does 2) say "after this trial Merck will get serious (maybe)"???   Other things 3) ...more  
153
Discussion
Post by billybobmontanaon Apr 07, 2021 8:07am

Public Relations

It's  good to see that the Merck relationship is moving forward, though the announcement requires reading between the lines.  Question today is to see with such news, does Fred and the ...more  
256
Discussion
Comment by Jthom376on Apr 07, 2021 7:59am

RE:RE:Hmm. So, collaboration continues?

Looks like a flat year on stock price. 
137
Discussion
Comment by Breakthoroughon Apr 07, 2021 7:55am

RE:Hmm. So, collaboration continues?

It looks like a continuation of Spirel for clarification, including an arm without cyclophosphamide and snd arm with DPX alone. Apart, the only two positive statement (no money involved) are: 1) " ...more  
211
Discussion
Post by alphaseeking001on Apr 07, 2021 7:30am

Hmm. So, collaboration continues?

Hi all, So... what the hell does this release mean this am?  Are there any Merck funds here??  Doesn't appear obvious that there is.  So little clarity.  Frustrating.  If ...more  
323
Discussion
Comment by TexasTea20on Apr 06, 2021 5:55pm

RE:RE:Just tossing it out there...

Jthom, I like it...except IMV doesnt have a COVID vaccine either.... but I guess thats your point. Ok back to work.
139
Discussion
Comment by Jthom376on Apr 06, 2021 5:49pm

RE:Just tossing it out there...

Texas.... I think you're right and I think Merck... who has no COVID vaccine, it going to pick up IMVs play! LOL
114
Discussion
Post by TexasTea20on Apr 06, 2021 5:43pm

Just tossing it out there...

Any thoughts on the possibiltiy that Merck, after having some sort of a gerneral agreement/understanding with IMV in place subject to PII DLBCL trial design approval by the FDA and further cost ...more  
212
Discussion
Comment by billybobmontanaon Apr 06, 2021 4:20pm

RE:RE:RE:RE:could be

 I'm sorry, but for the level of compensation this team receives, there are other more experienced biotech executives with greater product and public skill sets.  
96
Discussion
Comment by qwerty22on Apr 06, 2021 10:12am

RE:RE:RE:could be

My point would be for many investors the people steering the ship now are the same guys who were steering the ship when they invested, you can't expect them to suddenly become hotshot execs by ...more  
166
Discussion
Comment by billybobmontanaon Apr 06, 2021 8:01am

RE:RE:could be

Thank you for your comments Qwerty but an educated and experienced management team with an experienced board including a Chairman that really doesn't care about the investors wouldn't have a ...more  
200
Discussion
Comment by qwerty22on Apr 05, 2021 2:18pm

RE:could be

Speaking generally the options have narrowed for the company, that process goes all the way back to Incyte dropping out of Ovarian. It's been a rocky road from a data perspective since then and I& ...more  
255
Discussion
Post by europe10on Apr 05, 2021 10:02am

could be

Could be, barring in mind the extreme negative sentiment here, that we have seen the low for now. Agree that the board is useless, totally neglecting retail investors - or all shareholders for that ...more  
294
Discussion
Post by billybobmontanaon Apr 05, 2021 9:27am

Very weak

Unfortunately, even with an expected Merck announcement, management does not have an IR/PR plan in place and the people that are payroll are very weak.  Very little public investment exposure ...more  
197
Comment by avenuemanon Apr 04, 2021 4:34pm

RE:Reality Check

You 100% in your analysis. Pity the board is asleep at the wheel. 
159
Discussion
Prev ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities